AI-generated summary
This review article describes transcranial low-level light therapy, using red and near-infrared light from lasers or LEDs, and discusses proposed mechanisms in animals and humans. The authors report that the treatment may be a potential non-invasive option for cognitive impairment and related deficits, with effects linked to cytochrome oxidase activity and mitochondrial respiration. The abstract does not report a new clinical result from a specific study.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a narrative review and does not report pooled results, sample sizes, or clinical outcome data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dose, Photobiomodulation, Near-infrared, Photon, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.